Explore more publications!
Texas Technology Digest
Got News to Share?

Texas Technology Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Texas Technology Digest.

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

Press releases published on February 20, 2026

Future Healthcare Facilities Summit 2026 Dallas Connects Hospital Leaders and Infrastructure Partners
14 minutes ago

Future Healthcare Facilities Summit 2026 Dallas Connects Hospital Leaders and Infrastructure Partners

Indeterminate EIN Presswire
CodeSol Technologies Helps Businesses in Austin, Texas Save 1,000+ Hours Annually with Workflow Automation
4 hours ago

CodeSol Technologies Helps Businesses in Austin, Texas Save 1,000+ Hours Annually with Workflow Automation

Indeterminate EIN Presswire
FlexRadio, Inc. Announces Royal Communications, Inc. as a Value-Added Resale Partner for Commercial & Government Markets
6 hours ago

FlexRadio, Inc. Announces Royal Communications, Inc. as a Value-Added Resale Partner for Commercial & Government Markets

Indeterminate EIN Presswire
Collective 54 Celebrates the 250th Episode of Pro Serv Podcast
6 hours ago

Collective 54 Celebrates the 250th Episode of Pro Serv Podcast

Indeterminate EIN Presswire
PowerX Optimizer Releases Version 3.7.0 Featuring WealthOS Goals Financial Freedom Tool and Charles Schwab Integration
6 hours ago

PowerX Optimizer Releases Version 3.7.0 Featuring WealthOS Goals Financial Freedom Tool and Charles Schwab Integration

Indeterminate EIN Presswire
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
an hour ago

Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
an hour ago

CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
an hour ago

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Foresight Announced ADS Ratio Change
an hour ago

Foresight Announced ADS Ratio Change

Indeterminate GlobeNewswire
Averin Capital Acquisition Corp. Completes $250,000,000 Initial Public Offering
an hour ago

Averin Capital Acquisition Corp. Completes $250,000,000 Initial Public Offering

Indeterminate GlobeNewswire
aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
an hour ago

aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Amicus Therapeutics Announces Full-Year 2025 Financial Results and Corporate Updates
an hour ago

Amicus Therapeutics Announces Full-Year 2025 Financial Results and Corporate Updates

Indeterminate GlobeNewswire
Eupraxia Pharmaceuticals Announces Closing of US$63.2 Million Public Offering Including Full Exercise of Underwriter Option
2 hours ago

Eupraxia Pharmaceuticals Announces Closing of US$63.2 Million Public Offering Including Full Exercise of Underwriter Option

Indeterminate GlobeNewswire
Inscope Raises $14.5M Series A to Replace Manual Financial Statement Preparation for Accounting Firms and Enterprises
2 hours ago

Inscope Raises $14.5M Series A to Replace Manual Financial Statement Preparation for Accounting Firms and Enterprises

Indeterminate GlobeNewswire
U.S. Food and Drug Administration (FDA) Accepts Teva’s New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophrenia in Adults
2 hours ago

U.S. Food and Drug Administration (FDA) Accepts Teva’s New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophrenia in Adults

Indeterminate GlobeNewswire
Sadhguru Presents Innovative AI Hologram Tech at Massive Event
4 hours ago

Sadhguru Presents Innovative AI Hologram Tech at Massive Event

Indeterminate GlobeNewswire
Media87 Named 2026’s Top Digital Marketing Agency and Local SEO Leader
6 hours ago

Media87 Named 2026’s Top Digital Marketing Agency and Local SEO Leader

Indeterminate GlobeNewswire
ESET’s Ryan Grant Named a 2026 CRN Channel Chief
6 hours ago

ESET’s Ryan Grant Named a 2026 CRN Channel Chief

Indeterminate GlobeNewswire
Photonic Inc. Appoints New Executive Chair and Four New Directors to its Board of Directors
7 hours ago

Photonic Inc. Appoints New Executive Chair and Four New Directors to its Board of Directors

Indeterminate GlobeNewswire
ADARx Pharmaceuticals to Present Onvuzosiran (ADX-324) Phase 1/2 Clinical Data and Phase 3 Design at the 2026 AAAAI Annual Meeting
7 hours ago

ADARx Pharmaceuticals to Present Onvuzosiran (ADX-324) Phase 1/2 Clinical Data and Phase 3 Design at the 2026 AAAAI Annual Meeting

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions